LifeStance Health (LFST) Current Assets (2020 - 2026)

LifeStance Health has disclosed Current Assets across 7 years of filings, most recently posting $355.9 million for Q1 2026.

• In Q1 2026, Current Assets rose 16.83% year-over-year to $355.9 million; the TTM figure through Mar 2026 stood at $355.9 million (up 16.83% YoY), while the FY2025 annual figure was $416.2 million, up 33.18% from the prior year.
• Current Assets fell to $355.9 million in Q1 2026, from $416.2 million in the prior quarter.
• Over the last five years, Current Assets for LFST reached as high as $416.2 million in Q4 2025 and fell as low as $212.5 million in Q1 2023.
• The 5-year median for Current Assets is $264.2 million (2023), against an average of $285.4 million.
• Annual changes were most pronounced in 2022 — Current Assets slumped 32.9% — and 2024, when it jumped 38.44%.
• A 5-year view of Current Assets shows it stood at $233.2 million in 2022, then fell by 3.21% to $225.7 million in 2023, then jumped by 38.44% to $312.5 million in 2024, then soared by 33.18% to $416.2 million in 2025, then decreased by 14.49% to $355.9 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $355.9 million, $416.2 million, and $360.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.